Mirae Asset Global Investments
MENS

Mirae Asset Global Investments’s Jyong Biotech MENS Stock Holding History

Mirae Asset Global Investments’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04K Sell
3,400
-472
-12% -$1K ﹤0.01% 1607
2026
Q1 		$8.32K Buy
3,872
+178
+5% +$435 ﹤0.01% 1512
2025
Q4 		$14.6K Buy
+3,694
New +$130K ﹤0.01% 1577

Other funds holding MENS

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments's MENS Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Jyong Biotech (MENS) stake by 12% in Q2 2026, selling an estimated $1K and leaving 3,400 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

Mirae Asset Global Investments first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $14.6K in Q4 2025. 2 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Mirae Asset Global Investments held 3,400 shares of Jyong Biotech worth $7.04K as of Q2 2026.
  • Mirae Asset Global Investments sold 472 Jyong Biotech shares in Q2 2026, an estimated $1K.
  • Jyong Biotech made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1607 holding.
  • Mirae Asset Global Investments first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Jyong Biotech position peaked at $14.6K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.